Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
US FDA To Advisory Committee Industry Reps: Don’t Talk Too Much
Jul 12 2025
•
By
Sue Sutter
FDA believes advisory committee industry reps should be seen but not heard.
(Shutterstock)
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from US Advisory Committees
More from United States